Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
Holders of 5% or more of VRNA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Verona Pharma plc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 13G | 6.00%27.6M shares | New | Oct 17, 20251 filing | Oct 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
42 Schedule 13D and 13G filings on Verona Pharma plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:27 PM ET | Pentwater Capital Management LPand 1 other | 13G | 0.00%0 shares | NewBelow 5% | Sep 30, 2025 | SEC |
| Nov 14, 20254:00 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 0.00%0 shares | −6.40 ppfrom 6.40%Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 202510:24 AM ET | Janus Henderson Group PLC | 13G/A | 1.20%1.01M shares | −6.00 ppfrom 7.20%Below 5% | Sep 30, 2025 | SEC |
| Oct 17, 202512:45 PM ET | BlackRock Portfolio Management LLC | 13G | 6.00%27.6M shares | New | Sep 30, 2025 | SEC |
| Aug 14, 20256:14 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 0.70%593.7K shares | −6.40 ppfrom 7.10%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20254:15 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 6.40%5.51M shares | – | Jun 30, 2025 | SEC |
| Aug 14, 202511:27 AM ET | Janus Henderson Group PLC | 13G/A | 7.20%6.13M shares | +0.70 ppfrom 6.50% | Jun 30, 2025 | SEC |
| May 15, 20254:49 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 7.10%6.01M shares | −1.80 ppfrom 8.90% | Mar 31, 2025 | SEC |
| May 14, 202511:47 AM ET | Janus Henderson Group PLC | 13G | 6.50%5.54M shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20256:43 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 8.90%7.78M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20254:15 PM ET | Maverick Capital Ltdand 2 othersSuperinvestorMaverick Capital | 13G/A | 3.80%25.0M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 21, 20258:33 PM ET | Growth Equity Opportunities Fund IV, LLCand 16 others | 13D/A | 4.99%32.7M shares | –Below 5% | Jan 16, 2025 | SEC |
| Nov 14, 2024 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Maverick Capital LtdSuperinvestorMaverick Capital | 13GOld format | – | New | – | SEC |
| Nov 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 13, 2024 | Vivo Ventures VII, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Aug 28, 2024 | Growth Equity Opportunities Fund IV, LLC | 13D/AOld format | – | – | – | SEC |
| Jul 29, 2024 | Perceptive Advisors LLC | 13GOld format | – | – | – | SEC |
| Jul 12, 2024 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13GOld format | – | New | – | SEC |
| Feb 8, 2024 | Wellington Management Group LLP | 13GOld format | – | – | – | SEC |
| May 16, 2023 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Apr 25, 2023 | Access Industries Holdings LLC | 13G/AOld format | – | – | – | SEC |
| Apr 20, 2023 | Perceptive Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Vivo Ventures VII, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Access Industries Holdings LLC | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Dec 27, 2022 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Sep 7, 2022 | Growth Equity Opportunities Fund IV, LLC | 13D/AOld format | – | – | – | SEC |
| Aug 12, 2022 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Aug 11, 2022 | Abingworth LLP | 13D/AOld format | – | – | – | SEC |
| Aug 10, 2022 | Access Industries Holdings LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Vivo Ventures VI, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Wellington Management Group LLP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 5, 2021 | Novo Holdings A/S | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
29 notices from officers, directors and other affiliates planning to sell Verona Pharma plc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jun 11, 20254:27 PM ET | David ZaccardelliDirector · Officer | 50.0K | $4.34M | Jun 11, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 11, 20254:26 PM ET | Mark HahnOfficer | 50.0K | $4.34M | Jun 11, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 27, 20254:33 PM ET | David ZaccardelliDirector · Officer | 50.0K | $3.75M | May 27, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 27, 20254:31 PM ET | Mark HahnOfficer | 50.0K | $3.75M | May 27, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 20, 20254:30 PM ET | Vikas SinhaDirector | 20.0K | $1.45M | May 20, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 15, 20254:25 PM ET | Andrew FisherOfficer | 30.0K | $2.02M | May 15, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 14, 20254:32 PM ET | Christina AckermannDirector | 5.00K | $337.9K | May 14, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 6, 20254:33 PM ET | Kathleen RickardOfficer | 14.4K | $1.04M | May 6, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 2, 20254:24 PM ET | Mark HahnOfficer | 50.0K | $3.61M | May 2, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 2, 20254:24 PM ET | David ZaccardelliDirector · Officer | 50.0K | $3.61M | May 2, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 29, 20254:21 PM ET | Vikas SinhaDirector | 20.0K | $1.38M | Apr 29, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 12, 20254:23 PM ET | Kathleen RickardOfficer | 9.91K | $621.2K | Mar 12, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 25, 20244:42 PM ET | Kathleen A RickardOfficer | 30.0K | $1.18M | Nov 25, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 12, 20247:55 AM ET | Mark HahnOfficer | 125.0K | $4.82M | Nov 11, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 12, 20247:55 AM ET | David ZaccardelliDirector · Officer | 125.0K | $4.82M | Nov 11, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Oct 18, 20244:20 PM ET | Mark HahnOfficer | 100.0K | $3.47M | Oct 18, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Oct 18, 20244:20 PM ET | David ZaccardelliDirector · Officer | 100.0K | $3.47M | Oct 18, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 11, 20244:22 PM ET | Mark HahnOfficer | 75.0K | $2.10M | Sep 11, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 11, 20244:22 PM ET | David ZaccardelliDirector · Officer | 75.0K | $2.10M | Sep 11, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 12, 20244:20 PM ET | David ZaccardelliOfficer | 50.0K | $1.13M | Aug 12, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 12, 20244:20 PM ET | Mark HahnOfficer | 50.0K | $1.13M | Aug 12, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 12, 20247:45 PM ET | Rishi GuptaFormer director | 56.2K | $894.1K | Mar 12, 2024 | Morgan Stanley Smith Barney | SEC |
| Mar 4, 20248:15 PM ET | OrbiMed Private Investments VI, LPShareholder | 1.00M | $18.2M | Mar 4, 2024 | Themis Trading LLC | SEC |
| Feb 5, 20244:19 PM ET | Kathleen RickardOfficer | 9.06K | $165.9K | Feb 5, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 3, 20234:25 PM ET | Kathleen RickardOfficer | 7.34K | $109.7K | Nov 3, 202310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the VRNA notices from the last 12 months